511 related articles for article (PubMed ID: 8185423)
21. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
[TBL] [Abstract][Full Text] [Related]
22. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
Liam CK; Lim KH; Wong CM
Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
[TBL] [Abstract][Full Text] [Related]
23. [Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy].
Krenke R; Safianowska A; Paplińska M; Korczyński P; Dmowska-Sobstyl B; Bogacka-Zatorska E; Jaworski A; Chazan R
Pneumonol Alergol Pol; 2008; 76(4):237-45. PubMed ID: 18785128
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of soluble interleukin 2 receptor and adenosine deaminase levels in tuberculous and other etiologies pleural fluids].
Avilés Inglés MJ; Contessotto C; Ontañón J; Muro M; Berlinches P; de la Torre J; Sánchez Gascón F; Alvarez López MR
Arch Bronconeumol; 1996 Dec; 32(10):523-6. PubMed ID: 9019312
[TBL] [Abstract][Full Text] [Related]
25. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
26. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases].
Tada A; Kawahara S; Horita N; Horiba A; Tamaoki A; Okada C; Mishima Y; Soda R; Takahashi K
Kekkaku; 1999 Jun; 74(6):499-505. PubMed ID: 10423961
[TBL] [Abstract][Full Text] [Related]
27. [The diagnostic usefulness of cholinesterase in pleural exudates].
García Pachón E; Padilla Navas I
Rev Clin Esp; 1997 Jun; 197(6):402-5. PubMed ID: 9304130
[TBL] [Abstract][Full Text] [Related]
28. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
29. [The role of thoracoscopy in pleural biopsy in cases with pleural effusion].
Kimura M; Nakamura J; Tomizawa S; Adachi M; Tano Y; Matsushima T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):882-8. PubMed ID: 2214427
[TBL] [Abstract][Full Text] [Related]
30. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
Tian RX; Gao ZC
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of gamma-interferon in tuberculous pleurisy.
Poyraz B; Kaya A; Ciledağ A; Oktem A; Gönüllü U
Tuberk Toraks; 2004; 52(3):211-7. PubMed ID: 15351932
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of three tumor markers determined in pleural effusions.
Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
[TBL] [Abstract][Full Text] [Related]
33. [Pleural effusions--experience of Pneumo-phtisiology Hospital Tudor Vladimirescu--I: Clinical study].
Olaru M; Pleşea IE; Mălăescu D; Olaru R
Pneumologia; 2008; 57(3):138-46. PubMed ID: 18998326
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
35. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
36. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of human immunodeficiency virus infection: its impact on the diagnostic yields in exudative pleural effusions at the Kenyatta National Hospital, Nairobi.
Owino EA; McLigeyo SO; Gathua SN; Nyong'o A
East Afr Med J; 1996 Sep; 73(9):575-8. PubMed ID: 8991236
[TBL] [Abstract][Full Text] [Related]
38. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions.
Wang PS; Chen YM; Hsieh YL; Yu CF; Tsai CM; Perng RP
Lung; 2002; 180(1):25-32. PubMed ID: 12105754
[TBL] [Abstract][Full Text] [Related]
39. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
